<--- Back to Details
First PageDocument Content
Nitriles / Non-nucleoside reverse transcriptase inhibitors / Pyrimidines / Health / Pandemics / Darunavir / Antiretroviral drug / HIV / Rilpivirine / HIV/AIDS / Chemistry / Organic chemistry
Date: 2012-07-18 12:14:17
Nitriles
Non-nucleoside reverse transcriptase inhibitors
Pyrimidines
Health
Pandemics
Darunavir
Antiretroviral drug
HIV
Rilpivirine
HIV/AIDS
Chemistry
Organic chemistry

Global HIV Access & Partnerships Program GAPP Status: Optimizing Use of Our HIV Medicines in Resource-Limited Countries AT JANSSEN, we are committed to helping people living with HIV in resource-limited settings by ensur

Add to Reading List

Source URL: www.janssenrnd.com

Download Document from Source Website

File Size: 245,14 KB

Share Document on Facebook

Similar Documents

BMS_Gilead_Logo_FINAL.eps

BMS_Gilead_Logo_FINAL.eps

DocID: 1m38a - View Document

New Zealand Consumer Medicine Information  Viramune Tablets and Oral Suspension Nevirapine

New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension Nevirapine

DocID: 1gvCL - View Document

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

DocID: 1gtrY - View Document

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

DocID: 1fNy0 - View Document

1 DECEMBER  Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

1 DECEMBER Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

DocID: 1fw0V - View Document